Memantine Hydrochloride Memantine HCl CAS 41100-52-1 Assay 99.0% ~ 101.0% API
Mai ƙera tare da Babban Tsafta da Ƙarfin Ƙarfi
Sunan Sinadari: Memantine Hydrochloride
Saukewa: 41100-52-1
Memantine Hydrochloride a cikin maganin cutar Alzheimer
API USP Standard, High Quality, Commercial Production
Sunan Sinadari | Memantine Hydrochloride |
Makamantu | Memantine HCl;3,5-Dimethyl-1-adamantanamine Hydrochloride |
Lambar CAS | 41100-52-1 |
Lambar CAT | RF-API43 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: C12H22ClN |
Nauyin Kwayoyin Halitta | 215.76 |
Matsayin narkewa | 292 ℃ |
Yanayin jigilar kaya | Karkashin Zazzabi |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari ko Kashe-White Crystal Foda |
Ganewa | IR |
Asara akan bushewa | ≤0.50% |
Karfe masu nauyi (Pb) | ≤10ppm |
Abubuwa masu alaƙa | |
1-Methyladamantane | ≤0.30% (CAS 768-91-2) |
1,3,5-Trimethyladamantane | ≤0.30% (CAS 707-35-7) |
Duk Wani Tsaftar da Ba a Sani ba | ≤0.10% |
Jimlar ƙazanta | ≤0.50% |
Residual Solvent | Ethanol ≤0.05% |
Residual Solvent | Ethylacetate ≤0.05% |
Kwayoyin cuta Microbiologica | Max 5*102 aerobes da fungi da 1g Babu Escherichia coli |
Girman Abubuwan Rarraba | Wuce 100um |
pH | 4.5 ~ 6.5 |
Assay | 99.0% ~ 101.0% (a kan busassun tushe) |
Matsayin Gwaji | USP Standard |
Amfani | Sinadarin Magunguna Mai Aiki (API);Cutar Alzheimer |
Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.
Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai samar da Memantine Hydrochloride (CAS: 41100-52-1) tare da inganci mai inganci.
Memantine Hydrochloride (CAS: 41100-52-1) sanannen maganin neuroprotective ne wanda ake amfani dashi don maganin cutar Alzheimer.An yi imanin shine farkon maganin neuroprotective wanda ya sami amincewar asibiti ta Amurka FDA da Turai.
Memantine Hydrochloride, antagonist mai karɓa na NMDA, an haɗa shi ta hanyar Laboratories Forest tare da Merz Pharmaceuticals kuma an sayar da su a ƙarƙashin sunan kasuwanci na Namenda don maganin cutar Alzheimer a Amurka bayan amincewarsa a watan Oktoba, 2003. Wannan magani yana samuwa a yawancin Turai. da kasuwannin Asiya kafin samun amincewa a Amurka.